Tandem t:slim X2 User Manual page 309

The following table compares the percent of time spent between 70–180 mg/dL across the different baseline HbA1c values
observed in the DCLP3 study in both treatment groups.
Percentage of Time in Range per Study Arm by Baseline HbA1c (N=168)
Baseline HbA1c
≤6.5
6.6–7.0
7.1–7.5
7.6–8.0
≥8.1
The following table compares the average HbA1c values for all participants at baseline to, after 13-weeks, and 26-weeks. There
was a relative difference of -0.33% between the Control-IQ technology group and the SAP group.
Comparison of HbA1c Values (N=168)
Time Period
Baseline
After 13 Weeks
After 26 Weeks
CHAPTER 32 • Overview of Control-IQ Technology Clinical Studies
Time in Range
Control-IQ
85%
76%
71%
69%
60%
Control-IQ
7.40
7.02
7.06
SAP
78%
69%
49%
56%
47%
SAP
7.40
7.36
7.39
307